Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Portal Monaco.
Press releases published on June 13, 2025

GT Biopharma Appoints New Member to its Board of Directors
SAN FRANCISCO, CALIFORNIA, June 13, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer …

Through the cloud mining platform RIPPLECOIN Mining, the gap between the rich and the poor can be narrowed with one click
Seattle, Washington, June 13, 2025 (GLOBE NEWSWIRE) -- In today's digital economy, unequal wealth gap is becoming the biggest obstacle to social progress. While you are still working honestly and earning little, it is difficult to get rid of the …

RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for …

Lily AI Launches Solution to Optimize Product Content for Algorithmic and Generative Engine Discoverability
MOUNTAIN VIEW, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Lily AI (“Lily” or the “Company”), a retail technology company specializing in AI solutions for retailers and brands, announced today the launch of a new solution designed to empower marketers to …

VERSES Announces Conversion of Analog to Genius Enterprise after successful UAE Pilot
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation agentic software systems, announces that following a …

Tiziana Life Sciences to Present at the Bio International Convention
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …

Introducing Surfshark Everlink: patented self-healing VPN infrastructure for stable VPN protection
Surfshark, a leading provider of VPN services, unveils Surfshark Everlink, an industry-first patented (patents: US11190491B1, US20240080302A1) technology designed to deliver greater VPN connection stability. Surfshark Everlink is a supporting, self-healing …

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …

Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025
Interim analysis shows misetionamide is very well tolerated in combination with gemcitabine; rates of confirmed response, stable disease, and progression-free survival compare favorably with gemcitabine monotherapy BERWYN, PA, June 13, 2025 (GLOBE NEWSWIRE …

June 2025 Letter to Shareholders of Nvni Group Limited
~ Building on a Strong Foundation through Operational Progress and Strategic Initiatives ~ NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private B2B SaaS companies in …

Official Announcement: Legal Statement on Trademark and App Name by RBH
San Diego, USA, June 13, 2025 (GLOBE NEWSWIRE) -- Today, RBH Infinity Exchange has issued a legal statement regarding its trademark and app name. The full text is as follows: This exchange and all its operations, services, products, and visual identifiers …

ALL4 Mining Launches User-Friendly Free Cloud Mining Platform to Support Cryptocurrency Enthusiasts Worldwide
Buffalo, NY, June 13, 2025 (GLOBE NEWSWIRE) -- ALL4 Mining, a cloud mining platform founded in 2019, has announced the global expansion of its mining services, aiming to make cryptocurrency investment more accessible to both new and existing investors. …

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will …

Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions
GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation and …

reAlpha Expands Homebuying Platform into Texas, Marking First Step in National Realty Rollout
DUBLIN, Ohio, June 13, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced the expansion of its platform into Texas1 with the launch of real estate brokerage …

DN Miner Rolls Out Continuous Platform Upgrades to Redefine Cloud Mining Simplicity
London, UK, June 13, 2025 (GLOBE NEWSWIRE) -- In a rapidly evolving crypto landscape, DN Miner is staying ahead of the curve by investing in ongoing user interface and experience improvements, setting a new benchmark for simplicity and usability in the …

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON, June 13, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the …

Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
– ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (also known as AITL) and transformed follicular lymphoma – – In combination with small molecule inhibitors, ARV-393 …

ORLADEYO® (berotralstat) Approved in Colombia
RESEARCH TRIANGLE PARK, N.C., June 13, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the National Institute of Drug and Food Surveillance (INVIMA) in Colombia has granted approval for oral, once-daily ORLADEYO …

Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
Mr. Hunter brings more than 40 years of experience building and leading commercial organizations in the biopharmaceutical industry, including leadership roles at Validus Pharmaceuticals, Relialab and Novartis Led launch of Tonix Medicines, acquisition of …